HIPPO (sudeng) fluctuated by 73.2% in 24 hours: trading volume surge drives speculative rebound
Bitget Pulse2026/05/11 16:02Brief Volatility Overview
In the past 24 hours, the price of HIPPO rebounded from a low of $0.000280 to a high of $0.000485 and is currently reported at $0.000335, with an amplitude of 73.2%. Trading volume expanded significantly, reaching approximately $2.49–8.38 million, a 97.9%–106.7% increase compared to the previous period.
Analysis of Abnormal Movement Causes
- Trading volume surge: Within 24 hours, trading volume soared by 97.9%–106.7% to $2.49–3.91 million, driving the price to rebound from the low of $0.000215–$0.000229 to $0.000319–$0.000370.
- Active speculative trading: Bitget data shows market activity fluctuations of 42.5%–43.9%, triggering a price rebound, with no clear official announcements or significant on-chain whale movements observed.
Market Views and Outlook
The mainstream sentiment in the community is optimistic, viewing HIPPO as a leading low market cap (around $3–4 million) meme coin on the SUI chain. It has broken through its historical trend line with a market cap target of up to $50 million, but high volatility risks remain. Analysts predict the short-term price range at $0.00025–$0.00037.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring and is for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
RBA set to hike interest rate to 4.60% in September as inflation remains elevated
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
AMD (AMD.US) Surpasses $1 Trillion Market Cap and Begins Competing for "Computing Power Definition Rights"! Officially Announces $8.2 Billion Acquisition of Fei-Fei Li's World Labs
AMD has agreed to acquire World Labs for $8.2 billion, thereby gaining access to the artificial intelligence startup founded by industry pioneer and researcher Fei-Fei Li. This acquisition is expected to help AMD plan its future hardware launches by bringing in a team of top researchers and their models, as well as deep insights into trends in the field of artificial intelligence.
Crypto prices
More
